John D Quisel sold $806k of IRON
Chief Executive Officer at Disc Medicine, Inc.. 13,012 shares at an average of $61.95, traded Dec 30, 2024, filed Jan 2, 2025.
Score components
- +25RoleCEO
- +22Trade size$806k at market
- +5Share of holdings soldSold 15% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-000617, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 30, 2024 | MOption exercise Common Stock10b5-1 | +13,012 | $9.86 | $128k | 85,077 | Jan 2, 2025 |
| Dec 30, 2024 | SOpen-market sale Common Stock10b5-1 | -11,112 | $61.87 | $687k | 73,965 | Jan 2, 2025 |
| Dec 30, 2024 | SOpen-market sale Common Stock10b5-1 | -1,900 | $62.41 | $119k | 72,065 | Jan 2, 2025 |
| Dec 31, 2024 | MOption exercise Common Stock10b5-1 | +10,000 | $1.01 | $10k | 82,065 | Jan 2, 2025 |
| Dec 30, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -13,012 | $0.00 | $0 | 155,375 | Jan 2, 2025 |
| Dec 31, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 215,420 | Jan 2, 2025 |
Related signals
Other insiders at Disc Medicine, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | IRONsell Disc Medicine, Inc. | Kevin Bitterman director | $1.9M 27,136 shares | -100% | |
| 6Weak | Disc Medicine, Inc. | Kevin Bitterman director | $135k 1,689 shares | -1% | |
| 25Weak | Disc Medicine, Inc. | Kevin Bitterman director | $4.4M 54,496 shares | -16% | |
| 38Weak | Disc Medicine, Inc. | Kevin Bitterman director | $69k 754 shares | -0% | |
| 50Moderate | Disc Medicine, Inc. | Kevin Bitterman director | $17M 184,123 shares | -42% | |
| 40Moderate | Disc Medicine, Inc. | William Jacob Savage Chief Medical Officer | $1.2M 13,093 shares | -15% | |
| 35Weak | Disc Medicine, Inc. | John D Quisel Chief Executive Officer | $3.7M 40,000 shares | -19% | |
| 20Weak | Disc Medicine, Inc. | Jonathan Yen-Wen Yu Chief Operating Officer | $2.5M 30,000 shares | -43% | |
| 50Moderate | Disc Medicine, Inc. | Ai Dmi LLC owner | $60M 744,047 shares | -21% | |
| 53Moderate | Disc Medicine, Inc. | Kevin Bitterman director | $8.0M 93,585 shares | -19% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.